CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Illumina Cambridge's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 17, 2021Labelled Nucleotides1
Apr 22, 2020Modified Nucleotides1
Apr 8, 2020Modified Nucleotides For Polynucleotide Sequencing1
Dec 25, 2019Labelled Nucleotides2
Apr 3, 2019Method Of Preparing Libraries Of Template Polynucleotides1
Sep 26, 2018Labelled Nucleotides1
Feb 28, 2018Modified Nucleotides For Polynucleotide Sequencing2

Top competitors of Illumina Cambridge

Top competitors of Illumina Cambridge based on patent oppositions.